Clinical features may guide the selection of targeted genetic tests, for example cytogenetic tests such as fluorescence in situ hybridization (FISH) or comparative genomic hybridisation (CGH) where there are features of 22q11.2del, CHD7 sequencing for CHARGE syndrome, and FOXN1 for nude SCID. Here, FOXN1 is linked to CHARGE syndrome.